247 related articles for article (PubMed ID: 16161954)
1. [Serum iron parameters in chronic hepatitis C patients and comparison of the results before and during antiviral treatment].
Bolewska B; Wojtacha A; Juszczyk J; Przedwojewski M
Pol Merkur Lekarski; 2005 May; 18(107):552-5. PubMed ID: 16161954
[TBL] [Abstract][Full Text] [Related]
2. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
[TBL] [Abstract][Full Text] [Related]
3. Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C.
Hofer H; Osterreicher C; Jessner W; Penz M; Steindl-Munda P; Wrba F; Ferenci P
J Hepatol; 2004 Jun; 40(6):1018-22. PubMed ID: 15158344
[TBL] [Abstract][Full Text] [Related]
4. State of the iron metabolism in patients with chronic hepatitis C type C does not influence antiviral treatment with interferon and ribavirin.
Jurczyk K; Karpińska E; Wawrzynowicz-Syczewska M; Morańska I; Noceń I; Chlubek D; Boroń-Kaczmarska A
Hepatogastroenterology; 2008; 55(82-83):557-61. PubMed ID: 18613407
[TBL] [Abstract][Full Text] [Related]
5. Influence of hepatitis C virus (HCV) infection on porphyrin and iron metabolism in porphyria cutanea tarda (PCT) patients.
Dabrowska E; Jabłońska-Kaszewska I; Bielawski KP; Falkiewicz B
Med Sci Monit; 2001 May; 7 Suppl 1():190-6. PubMed ID: 12211718
[TBL] [Abstract][Full Text] [Related]
6. Effect of iron depletion on serum markers of fibrogenesis, oxidative stress and serum liver enzymes in chronic hepatitis C: results of a pilot study.
Alexander J; Tung BY; Croghan A; Kowdley KV
Liver Int; 2007 Mar; 27(2):268-73. PubMed ID: 17311623
[TBL] [Abstract][Full Text] [Related]
7. Iron overload in patients with chronic viral hepatitis: how common is it?
Riggio O; Montagnese F; Fiore P; Folino S; Giambartolomei S; Gandin C; Merli M; Quinti I; Violante N; Caroli S; Senofonte O; Capocaccia L
Am J Gastroenterol; 1997 Aug; 92(8):1298-1301. PubMed ID: 9260793
[TBL] [Abstract][Full Text] [Related]
8. Response of chronic hepatitis C to interferon-alpha treatment and relationship with iron metabolism.
Martín-Vivaldi R; Nogueras F; González A; Quintero D; Pinel LM; Castro T; Hernández A
Rev Esp Enferm Dig; 1997 Jul; 89(7):523-30. PubMed ID: 9265838
[TBL] [Abstract][Full Text] [Related]
9. Association of hepatitis C virus infection with serum iron status: analysis of data from the third National Health and Nutrition Examination Survey.
Shan Y; Lambrecht RW; Bonkovsky HL
Clin Infect Dis; 2005 Mar; 40(6):834-41. PubMed ID: 15736017
[TBL] [Abstract][Full Text] [Related]
10. Monitoring iron status in end-stage renal disease patients on hemodialysis.
Rafi A; Karkar A; Abdelrahman M
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
[TBL] [Abstract][Full Text] [Related]
11. Dietary and serum iron, body iron stores and coronary heart disease.
Gupta R; Rastogi S; Nagar R; Kastia S; Kaul V
J Assoc Physicians India; 2000 May; 48(5):489-92. PubMed ID: 11273140
[TBL] [Abstract][Full Text] [Related]
12. [Studies on the change in the levels of serum ferritin, serum iron and total iron binding capacity caused by aging and sex difference].
Ueno Y; Fujita K; Takashina N; Chiba S; Uzuka Y; Kinouchi T; Shimizu N
Rinsho Byori; 1991 May; 39(5):523-30. PubMed ID: 2072576
[TBL] [Abstract][Full Text] [Related]
13. Diurnal variation of serum iron, iron-binding capacity, transferrin saturation, and ferritin levels.
Dale JC; Burritt MF; Zinsmeister AR
Am J Clin Pathol; 2002 May; 117(5):802-8. PubMed ID: 12090432
[TBL] [Abstract][Full Text] [Related]
14. Iron in hepatitis C: villain or innocent bystander?
Ioannou GN; Tung BY; Kowdley KV
Semin Gastrointest Dis; 2002 Apr; 13(2):95-108. PubMed ID: 12064865
[TBL] [Abstract][Full Text] [Related]
15. [Iron metabolism in patient infected by human immunodeficiency virus type 1].
Arévalo Velasco A; Mateo Rodríguez F; Sánchez Pérez MA; Alonso Claudio G; Pérez Arellano JL; Fuertes Martín A
Sangre (Barc); 1997 Oct; 42(5):345-9. PubMed ID: 9424732
[TBL] [Abstract][Full Text] [Related]
16. Iron and porphyria cutanea tarda.
D'Alessandro Gandolfo L; Griso D; Macrì A; Biolcati G; Barlattani A; Topi GC
Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):75-9. PubMed ID: 9074791
[TBL] [Abstract][Full Text] [Related]
17. [Anemia and iron metabolism in patients with type-2 diabetes mellitus].
Kovács F; Szakál I; Révész K; Lévai A; Dobos A
Orv Hetil; 2006 Feb; 147(8):345-9. PubMed ID: 16579333
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the serum ferritin and percentage of transferrin saturation as exposure markers of iron-driven oxidative stress-related disease outcomes.
Lee DH; Zacharski LR; Jacobs DR
Am Heart J; 2006 Jun; 151(6):1247.e1-7. PubMed ID: 16781229
[TBL] [Abstract][Full Text] [Related]
19. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
Chen YC; Hung SC; Tarng DC
Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
[TBL] [Abstract][Full Text] [Related]
20. [Concentration of ferritin, transferrin and iron as a markers of iron deficiency in healthy women in reproductive age].
Chełchowska M; Laskowska-Klita T; Leibschang J
Pol Merkur Lekarski; 2007 Jan; 22(127):25-7. PubMed ID: 17477085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
